These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 31492197)

  • 1. Neuromuscular blocking agents for acute respiratory distress syndrome: how did we get conflicting results?
    Torbic H; Krishnan S; Duggal A
    Crit Care; 2019 Sep; 23(1):305. PubMed ID: 31492197
    [No Abstract]   [Full Text] [Related]  

  • 2. Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome.
    Yoshida T; Kavanagh BP; Brochard L
    N Engl J Med; 2019 Aug; 381(8):786-787. PubMed ID: 31433933
    [No Abstract]   [Full Text] [Related]  

  • 3. Neuromuscular Blockade Applicability in Early Acute Respiratory Distress Syndrome.
    Hurford WE
    Anesthesiology; 2020 Jun; 132(6):1577-1584. PubMed ID: 32032097
    [No Abstract]   [Full Text] [Related]  

  • 4. Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome.
    Gallo de Moraes A; El-Yafawi R; Oeckler RA
    N Engl J Med; 2019 Aug; 381(8):787. PubMed ID: 31433934
    [No Abstract]   [Full Text] [Related]  

  • 5. Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome.
    Aquino Esperanza J; de Haro C; Blanch L
    N Engl J Med; 2019 Aug; 381(8):785-786. PubMed ID: 31433932
    [No Abstract]   [Full Text] [Related]  

  • 6. Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome.
    Brink M; Everaars N; de Pont AJM
    N Engl J Med; 2019 Aug; 381(8):785. PubMed ID: 31433931
    [No Abstract]   [Full Text] [Related]  

  • 7. Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome. Reply.
    Moss M; Ulysse CA; Angus DC;
    N Engl J Med; 2019 Aug; 381(8):787-788. PubMed ID: 31433935
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical Practice Guidelines for Sustained Neuromuscular Blockade in the Adult Critically Ill Patient.
    Murray MJ; DeBlock H; Erstad B; Gray A; Jacobi J; Jordan C; McGee W; McManus C; Meade M; Nix S; Patterson A; Sands MK; Pino R; Tescher A; Arbour R; Rochwerg B; Murray CF; Mehta S
    Crit Care Med; 2016 Nov; 44(11):2079-2103. PubMed ID: 27755068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Pharmacologic Paralysis in Acute Respiratory Distress Syndrome.
    Syed A; Kobzik A; Huang DT
    Semin Respir Crit Care Med; 2019 Feb; 40(1):101-113. PubMed ID: 31060092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and Rationale of the Reevaluation of Systemic Early Neuromuscular Blockade Trial for Acute Respiratory Distress Syndrome.
    Huang DT; Angus DC; Moss M; Thompson BT; Ferguson ND; Ginde A; Gong MN; Gundel S; Hayden DL; Hite RD; Hou PC; Hough CL; Iwashyna TJ; Liu KD; Talmor DS; Yealy DM;
    Ann Am Thorac Soc; 2017 Jan; 14(1):124-133. PubMed ID: 27779896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Markov computer simulation model of the economics of neuromuscular blockade in patients with acute respiratory distress syndrome.
    Macario A; Chow JL; Dexter F
    BMC Med Inform Decis Mak; 2006 Mar; 6():15. PubMed ID: 16539706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring of neuromuscular blockade: a comparison of train-of-four and the Campbell diagram.
    Baedorf Kassis E; Train S; MacNeil B; Loring SH; Talmor D
    Intensive Care Med; 2018 Dec; 44(12):2305-2306. PubMed ID: 30350170
    [No Abstract]   [Full Text] [Related]  

  • 13. Association Between Train-of-Four Values and Gas Exchange Indices in Moderate to Severe Acute Respiratory Distress Syndrome.
    Groetzinger LM; Rivosecchi RM; Kane-Gill SL; Donahoe MP
    Ann Pharmacother; 2016 Dec; 50(12):1009-1015. PubMed ID: 27511813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of a neuromuscular blocking agent could significantly decrease mortality in moderate-to-severe ARDS patients: is moderate ARDS the best indication for neuromuscular blocking agents.
    Honore PM; Mugisha A; Kugener L; Redant S; Attou R; Gallerani A; De Bels D
    Crit Care; 2020 May; 24(1):217. PubMed ID: 32404187
    [No Abstract]   [Full Text] [Related]  

  • 15. Neuromuscular Blockers in Acute Respiratory Distress Syndrome: Flat Dose or Not. Are We Missing the Point?
    Quintin L
    Crit Care Med; 2020 May; 48(5):e438. PubMed ID: 32301792
    [No Abstract]   [Full Text] [Related]  

  • 16. Extended neuromuscular blockade in acute respiratory distress syndrome does not increase mortality.
    Barmparas G; Dhillon NK; Tatum JM; Patel K; Thomsen GM; Mason R; Margulies DR; Ley EJ
    J Surg Res; 2018 Nov; 231():434-440. PubMed ID: 30278965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sedation, Neuromuscular Blockade, and Mortality in Acute Respiratory Distress Syndrome: Important Questions Remain.
    Train SE; Dieffenbach PB; Massaro AF; Devlin JW
    Crit Care Med; 2022 Jan; 50(1):e89-e90. PubMed ID: 34914654
    [No Abstract]   [Full Text] [Related]  

  • 18. Pilot Feasibility Study of Therapeutic Hypothermia for Moderate to Severe Acute Respiratory Distress Syndrome.
    Slack DF; Corwin DS; Shah NG; Shanholtz CB; Verceles AC; Netzer G; Jones KM; Brown CH; Terrin ML; Hasday JD
    Crit Care Med; 2017 Jul; 45(7):1152-1159. PubMed ID: 28406814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rescue Neuromuscular Blockade in Acute Respiratory Distress Syndrome Should Be Flat Dose.
    Co I; Hyzy RC
    Crit Care Med; 2020 Apr; 48(4):591-593. PubMed ID: 32205607
    [No Abstract]   [Full Text] [Related]  

  • 20. Rescue Neuromuscular Blockade in Acute Respiratory Distress Syndrome Should Not Be Flat Dose.
    Flannery AH; Moss M
    Crit Care Med; 2020 Apr; 48(4):588-590. PubMed ID: 32205606
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.